Trial
NCT04634604
A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jaeb Center for Health Research
Collaborators
Pediatric Eye Disease Investigator Group; National Eye Institute (NEI)
Condition
Retinopathy of Prematurity
Intervention
Bevacizumab
Why stopped
Lack of feasibility to recruit.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-17